Olaparib routine clinical practice in Germany - Quality of life interim results of the non-interventional C-PATROL study

被引：0
|
作者：
El-Balat, A. [1 ]
Marme, F. [2 ]
Sehouli, J. [3 ]
Welslau, M. [4 ]
Grabowski, J. P. [5 ,6 ]
Hartkopf, A. [7 ]
Glowik, R. [8 ]
Hilpert, F. [9 ]
机构：
[1] Univ Klinikum Frankfurt, Klin Frauenheilkunde & Geburtshilfe, Frankfurt, Germany
[2] Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Gynecol, Mannheim, Germany
[3] Charite, Ctr Oncol Surg, Dept Gynecol, Berlin, Germany
[4] Med Off Hematooncol, Aschaffenburg, Aschaffenburg, Germany
[5] Charite, Dept Gynecol, Berlin, Germany
[6] Charite, Ctr Oncol Surg, Berlin, Germany
[7] Univ Hosp Tuebingen, Ctr Womens Hlth, Tubingen, Germany
[8] AstraZeneca Germany, Oncol, Wedel, Germany
[9] Jerusalem Hosp Hamburg, Ctr Oncol, Hamburg, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2020年 / 80卷 / 10期
关键词：
D O I：
10.1055/s-0040-1718133
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P304
引用
收藏
页码：E188 / E188
页数：1
相关论文
共 50 条
  • [21] Young adult RRMS patients treated with fingolimod in daily clinical practice: interim results of the non-interventional study PANGAEA
    Ziemsseni, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    Ettle, B.
    Schulze-Topphoff, U.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 500 - 500
  • [22] Interim analysis of the non-interventional QoLiTrap study - Quality of life, therapy management and progression-free survival data with Aflibercept and FOLFIRI from clinical practice in Germany, Austria and Switzerland
    Scholten, F.
    Derigs, G.
    Losem, C.
    Kroening, H.
    Windemuth-Kieselbach, C.
    Hoffmann, C. M.
    Zaun, S.
    Thaler, J.
    von Moos, R.
    Hofheinz, R. -D
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 199 - 199
  • [23] Privigen® in secondary immunodeficiencies - interim analysis of a multicenter non-interventional study in Germany
    Plath, M.
    Slawik, H. R.
    Reiser, M.
    Otremba, B.
    Pfruender, D.
    Oncology Research and Treatment, 2015, 38 : 77 - 77
  • [24] Interim analysis of the non-interventional QoLiTrap-study - therapy sequences, progression-free survival and quality of life in clinical practice with FOLFIRI and Aflibercept
    Derigs, G.
    Scholten, F.
    Frey, M.
    Kroening, H.
    Thaler, J.
    von Moos, R.
    Hofheinz, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 12 - 12
  • [25] NEPA for CINV prevention in highly or moderately emetogenic chemotherapy - interim results of a German non-interventional study on quality of life and efficacy
    Schilling, Joerg
    Klare, Peter
    Heilmann, Volker
    Wuelfing, Pia
    Karthaus, Meinolf
    CANCER RESEARCH, 2018, 78 (04)
  • [26] A non-interventional observational trial to study the COPD treatment choices in routine clinical practice in Bulgaria
    Glogovska, Pavlina Nikolova
    Ivanov, Yavor
    Nikolaev, Ivan
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [27] First interim results of IDELA PASS: a prospective non-interventional post authorization safety study of idelalisib in Germany
    Abenhardt, W.
    Knauf, W.
    Eissmann, P.
    Hucke, N.
    van Troostenburg, A.
    Watzke, S.
    Hoechstetter, M.
    Rummel, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 139 - +
  • [28] Use of lipegfilgrastim in clinical practice for the prophylaxis of chemotherapy-induced neutropenia: interim results of pan-European non-interventional study
    Pichler, P.
    Claes, N.
    Mazza, P.
    Zurawski, B.
    Potocki, P.
    Petru, E.
    Sediva, M.
    Katolicka, J.
    Lanza, F.
    Fontaine, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI - Interim results of the non-interventional study QoLiTrap
    Scholten, F.
    Derigs, G.
    Losem, C.
    Kroening, H.
    Windemuth-Kieselbach, C.
    Hofheinz, R. D.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 163 - 163
  • [30] A prospective, non-interventional study in US patients with relapsing-remitting multiple sclerosis treated with alemtuzumab in routine clinical practice (PROMiS): interim results on patient reported outcomes
    Khatri, B. O.
    Morawski, J.
    Chung, L.
    Poole, E.
    Bury, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 722 - 722
12345